These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Vulvar Hailey-Hailey disease treated with low-dose naltrexone: case report and literature review. Sousa Gomes M; Araújo Pereira J; Trocado V; Prata JP; Teixeira V; Pinheiro P Arch Gynecol Obstet; 2020 Nov; 302(5):1081-1086. PubMed ID: 32776297 [TBL] [Abstract][Full Text] [Related]
6. Naltrexone Therapy for Hailey-Hailey Disease: Confirming My Addiction to Evidence-Based Medicine. Heymann WR Skinmed; 2019; 17(1):44-45. PubMed ID: 30888948 [No Abstract] [Full Text] [Related]
7. Naltrexone for the Treatment of Darier and Hailey-Hailey Diseases. Jfri A; Litvinov IV; Netchiporouk E J Cutan Med Surg; 2019; 23(4):453-454. PubMed ID: 31337235 [No Abstract] [Full Text] [Related]
9. Low-dose naltrexone: a novel treatment for Hailey-Hailey disease. Campbell V; McGrath C; Corry A Br J Dermatol; 2018 May; 178(5):1196-1198. PubMed ID: 28991360 [TBL] [Abstract][Full Text] [Related]
10. Low-dose naltrexone in Hailey-Hailey disease: the importance of dosing. Acharya P; Mathur M Br J Dermatol; 2020 Jul; 183(1):193. PubMed ID: 32133619 [No Abstract] [Full Text] [Related]
11. Improvement of Hailey-Hailey disease with low-dose naltrexone. Jasans-Barceló M; Curman P; Hagströmer L; Wikstrom JD; Sairafi D Br J Dermatol; 2020 Jun; 182(6):1500-1502. PubMed ID: 31912486 [No Abstract] [Full Text] [Related]
12. Use of low-dose naltrexone in the treatment of severe Hailey-Hailey disease: One case report. Garayar Cantero M; Canseco Martín M; Aguado García Á; Ruiz-Sánchez D; Valtueña J; Manchado López P Dermatol Ther; 2019 May; 32(3):e12892. PubMed ID: 30958613 [TBL] [Abstract][Full Text] [Related]
13. The uses of naltrexone in dermatologic conditions. Lee B; Elston DM J Am Acad Dermatol; 2019 Jun; 80(6):1746-1752. PubMed ID: 30582992 [TBL] [Abstract][Full Text] [Related]
14. Hailey-Hailey disease: the role of azathioprine an immunomodulator. Malan M; Xuejingzi W; Si J; Quan SJ Pan Afr Med J; 2019; 32():65. PubMed ID: 31223357 [TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy with 5-aminolevulinic acid for recalcitrant familial benign pemphigus (Hailey-Hailey disease). Ruiz-Rodriguez R; Alvarez JG; Jaén P; Acevedo A; Córdoba S J Am Acad Dermatol; 2002 Nov; 47(5):740-2. PubMed ID: 12399767 [TBL] [Abstract][Full Text] [Related]
16. Benign familial chronic pemphigus (Hailey-Hailey disease) responds to cyclosporin. Berth-Jones J; Smith SG; Graham-Brown RA Clin Exp Dermatol; 1995 Jan; 20(1):70-2. PubMed ID: 7671404 [TBL] [Abstract][Full Text] [Related]
18. Is photodynamic therapy a relevant therapeutic option in refractory benign familial pemphigus (Hailey-Hailey disease)? A series of eight patients. Alsahli M; Debu A; Girard C; Bessis D; Du Thanh A; Guillot B; Dereure O J Dermatolog Treat; 2017 Nov; 28(7):678-682. PubMed ID: 28301978 [TBL] [Abstract][Full Text] [Related]
19. The effect of low-dose naltrexone on quality of life of patients with multiple sclerosis: a randomized placebo-controlled trial. Sharafaddinzadeh N; Moghtaderi A; Kashipazha D; Majdinasab N; Shalbafan B Mult Scler; 2010 Aug; 16(8):964-9. PubMed ID: 20534644 [TBL] [Abstract][Full Text] [Related]
20. Topical cyclosporine in chronic benign familial pemphigus (Hailey-Hailey disease). Jitsukawa K; Ring J; Weyer U; Kimmig W; Radloff H J Am Acad Dermatol; 1992 Oct; 27(4):625-6. PubMed ID: 1401318 [No Abstract] [Full Text] [Related] [Next] [New Search]